Not applicableStudy completedNCT05138523
What this trial is testing
Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)
Who this might be right for
Chronic Hepatitis c
Beker Laboratories 99